Patents by Inventor Samirkumar Patel

Samirkumar Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200228972
    Abstract: A device determines information concerning the device and sends the information concerning the device to a first device. The device receives, from the first device, information concerning a user device, and receives, from a second device, a request concerning the user device accessing the device. The request includes information identifying the device and information identifying the user device. The device generates a request response by validating the user device for access to the device based on the request and sends, to the second device, the request response to facilitate a communication session to be established between the user device and the device. The device communicates with the user device via the communication session.
    Type: Application
    Filed: January 10, 2019
    Publication date: July 16, 2020
    Inventors: Byunghun CHOI, Jyotsna KACHROO, Ray P. HWANG, Dayong HE, Samirkumar PATEL, Emilia C. QUIJANO, Young Rak CHOI, Warren Hojilla UY, Feng LUO, Manuel Enrique CACERES
  • Publication number: 20200169339
    Abstract: A fixed wireless access device may include a memory configured to store instructions and a processor configured to execute the instructions to activate a Fifth Generation (5G) scanning mode and scan for 5G wireless signals associated with a provider that is also associated with the fixed wireless access device. The processor may be further configured to detect a 5G wireless signal associated with the provider; determine a signal strength for the detected 5G wireless signal; and generate an indication of the determined signal strength to be displayed in a user interface associated with the fixed wireless access device.
    Type: Application
    Filed: January 28, 2020
    Publication date: May 28, 2020
    Inventors: Samirkumar Patel, Xin Wang, Paul R. Mcdonough, Andrew E. Youtz, Lily Zhu, Arda Aksu, Balaji L. Raghavachari, Siegfried Erhard Eichinger, Christopher M. Schmidt, Jignesh S. Panchal
  • Publication number: 20200154272
    Abstract: A first wireless access device, associated with a wireless service provider, establishes a wireless local area network connection with a second wireless access device and receives a certificate including a unique identifier associated with the second wireless access device. The first wireless access device determines whether the second wireless access device is authorized to connect to the first wireless access device. For example, if the certificate is signed by a certificate authority associated with the wireless service provider and the unique identifier appears in a whitelist stored at the first wireless access device, the first wireless access device and the second wireless access device perform a mutual authentication procedure based on one or more ephemeral keys. The first wireless access device provides the second wireless access device with access to a wide area network based on successful completion of the mutual authentication procedure.
    Type: Application
    Filed: November 14, 2018
    Publication date: May 14, 2020
    Inventors: Warren Hojilla UY, Young R. CHOI, Samirkumar PATEL
  • Publication number: 20200137816
    Abstract: A method, a device, and a non-transitory storage medium are described in which cell selection management service is provided. An Evolved Universal Terrestrial Radio Access-New Radio (E-UTRA-NR) Dual Connectivity (EN-DC) capable end device uses a system information block message to determine whether a wireless station is an EN-DC capable anchor device. Also, the EN-DC capable end device may store a permanent tracking area forbidden list that includes tracking area identifiers pertaining to non-EN-DC capable anchor devices that include femtocell devices.
    Type: Application
    Filed: October 31, 2018
    Publication date: April 30, 2020
    Inventors: Hui Zhao, Andrew E. Youtz, Xin Wang, Samirkumar Patel, Lily Zhu
  • Patent number: 10609627
    Abstract: A device can receive a system information data from a cell and obtain cell metadata from the system information data, the cell metadata including at least one of: a cell identifier, or a cellular parameter. The device can determine, based on the cell metadata, that the cell is of a particular cell type of multiple cell types, including: a fifth generation long term evolution (LTE) cell type, a fifth generation new radio (NR) sub-6 GHz cell type, and a fifth generation NR millimeter wave cell type. Based on the particular cell type, the device can perform an action, including causing display of an indicator on a display of the device.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: March 31, 2020
    Assignee: Verizon Patent and Licensing Inc.
    Inventors: Hui Zhao, Samirkumar Patel, Lily Zhu, Andrew E. Youtz, Christopher M. Schmidt
  • Publication number: 20200092935
    Abstract: A device, a computer-readable medium, and a method provide for determining, based on a network synchronization signal, a signal power value for a wireless communication; determining, based on the network synchronization signal, a signal quality value for the wireless communication; generating, using the signal power value and the signal quality value, a signal strength associated with a next generation network connection; determining a state of the device, wherein the state relates to a next generation network connection state and a fourth generation (4G)/Long Term Evolution (4G/LTE) network connection state of the device; providing for display a network indicator indicating whether the device is associated with a 4G/LTE network connection or the next generation network connection, wherein the network indicator is based on the state of the device; and providing, for display, a first signal indicator indicating the signal strength.
    Type: Application
    Filed: October 18, 2019
    Publication date: March 19, 2020
    Inventors: Xin WANG, Andrew E. YOUTZ, Hui ZHAO, Lily ZHU, Samirkumar PATEL, Balaji L. RAGHAVACHARI
  • Publication number: 20200076518
    Abstract: A fixed wireless access device may include a memory configured to store instructions and a processor configured to execute the instructions to activate a Fifth Generation (5G) scanning mode and scan for 5G wireless signals associated with a provider that is also associated with the fixed wireless access device. The processor may be further configured to detect a 5G wireless signal associated with the provider; determine a signal strength for the detected 5G wireless signal; and generate an indication of the determined signal strength to be displayed in a user interface associated with the fixed wireless access device.
    Type: Application
    Filed: September 5, 2018
    Publication date: March 5, 2020
    Inventors: Samirkumar Patel, Xin Wang, Paul R. Mcdonough, Andrew E. Youtz, Lily Zhu, Arda Aksu, Balaji L. Raghavachari, Siegfried Erhard Eichinger, Christopher M. Schmidt, Jignesh S. Panchal
  • Patent number: 10560204
    Abstract: A fixed wireless access device may include a memory configured to store instructions and a processor configured to execute the instructions to activate a Fifth Generation (5G) scanning mode and scan for 5G wireless signals associated with a provider that is also associated with the fixed wireless access device. The processor may be further configured to detect a 5G wireless signal associated with the provider; determine a signal strength for the detected 5G wireless signal; and generate an indication of the determined signal strength to be displayed in a user interface associated with the fixed wireless access device.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: February 11, 2020
    Assignee: Verizon Patent And Licensing Inc.
    Inventors: Samirkumar Patel, Xin Wang, Paul R. Mcdonough, Andrew E. Youtz, Lily Zhu, Arda Aksu, Balaji L. Raghavachari, Siegfried Erhard Eichinger, Christopher M. Schmidt, Jignesh S. Panchal
  • Publication number: 20190373523
    Abstract: A wireless station of a radio access network receives a reselection priority value of a frequency band used when the wireless station is an E-UTRA-NR Dual Connectivity (EN-DC) anchor. The wireless station broadcasts an intra-frequency system information block (SIB) that includes a first Cell Reselection Priority information element (IE) and a first Anchor-cell Reselection Priority IE, wherein the first Anchor-cell Reselection Priority IE includes the reselection priority value of the frequency band used by the wireless station. The wireless station also broadcast an inter-frequency SIB that includes a second Cell Reselection Priority IE and a second Anchor-cell Reselection Priority IE, wherein the second Anchor-cell Reselection Priority IE includes another reselection priority value of another frequency band for another EN-DC anchor.
    Type: Application
    Filed: June 1, 2018
    Publication date: December 5, 2019
    Inventors: Jignesh S. Panchal, Yuexin Dong, Andrew E. Youtz, Lily Zhu, Samirkumar Patel
  • Patent number: 10499449
    Abstract: A user equipment (UE) can determine a first measurement value and a second measurement value based on a 5G/New Radio (5G/NR) synchronization signal; determine a state of the UE, wherein the state relates to a 5G/NR connection state and a 4G/Long Term Evolution (4G/LTE) connection state of the UE; provide, for display, at least one network indicator indicating whether the UE is associated with a 4G/LTE connection and whether the UE is associated with a 5G/NR connection, wherein the at least one network indicator is based on the state; and provide, for display, at least one signal indicator indicating a signal strength associated with at least one of the 4G/LTE connection or the 5G/NR connection, wherein, when the signal strength is associated with the 5G/NR connection, the at least one signal indicator is based on the first measurement value and the second measurement value.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: December 3, 2019
    Assignee: Verizon Patent and Licensing Inc.
    Inventors: Xin Wang, Andrew E. Youtz, Hui Zhao, Lily Zhu, Samirkumar Patel, Balaji L. Raghavachari
  • Publication number: 20190335384
    Abstract: A device can receive a system information data from a cell and obtain cell metadata from the system information data, the cell metadata including at least one of: a cell identifier, or a cellular parameter. The device can determine, based on the cell metadata, that the cell is of a particular cell type of multiple cell types, including: a fifth generation long term evolution (LTE) cell type, a fifth generation new radio (NR) sub-6 GHz cell type, and a fifth generation NR millimeter wave cell type. Based on the particular cell type, the device can perform an action, including causing display of an indicator on a display of the device.
    Type: Application
    Filed: April 26, 2018
    Publication date: October 31, 2019
    Inventors: Hui ZHAO, Samirkumar PATEL, Lily ZHU, Andrew E. YOUTZ, Christopher M. SCHMIDT
  • Publication number: 20190307606
    Abstract: Devices, methods, and kits for ocular drug delivery are described herein. An apparatus can include a housing, an energy storage member, a barrel, and a hub. The housing contains the energy storage member. A proximal end portion of the barrel is coupled to a distal end portion of the housing. The barrel is configured to contain medicament and includes at least a portion of a piston and an elastomeric member. The piston is configured to move the elastomeric member within the barrel in response to a force produced by the energy storage member. The hub is coupled to a distal end portion of the barrel. An inner surface of the hub defines a nozzle through which the medicament flows when the elastomeric member moves within the barrel. The nozzle and the energy storage member are collectively configured to produce a fluid jet to access a target location within an eye.
    Type: Application
    Filed: November 1, 2018
    Publication date: October 10, 2019
    Inventors: Rafael Victor ANDINO, Thomas Edward GODFREY, Shelley Eckert HANCOCK, Samirkumar PATEL, Keleigh Jo MAHN, Jesse YOO, Vladimir ZARNITSYN
  • Publication number: 20190290485
    Abstract: Devices, methods, and kits for ocular drug delivery are described herein. In some embodiments, a method includes inserting a distal end portion of a puncture member into an eye to define a delivery passageway within the eye. The delivery passageway extends through ha sclera of the eye and a choroid of the eye. The delivery passageway is less than about 1.5 mm. The method further includes conveying a substance into a subretinal space within the eye via the distal end portion of the puncture member.
    Type: Application
    Filed: June 13, 2019
    Publication date: September 26, 2019
    Applicant: CLEARSIDE BIOMEDICAL, INC.
    Inventors: Rafael Victor ANDINO, Thomas Edward GODFREY, Shelley Eckert HANCOCK, Samirkumar PATEL, Keleigh Jo STRUDTHOFF, Jesse YOO, Vladimir ZARNITSYN
  • Publication number: 20190268962
    Abstract: A user equipment (UE) can determine a first measurement value and a second measurement value based on a 5G/New Radio (5G/NR) synchronization signal; determine a state of the UE, wherein the state relates to a 5G/NR connection state and a 4G/Long Term Evolution (4G/LTE) connection state of the UE; provide, for display, at least one network indicator indicating whether the UE is associated with a 4G/LTE connection and whether the UE is associated with a 5G/NR connection, wherein the at least one network indicator is based on the state; and provide, for display, at least one signal indicator indicating a signal strength associated with at least one of the 4G/LTE connection or the 5G/NR connection, wherein, when the signal strength is associated with the 5G/NR connection, the at least one signal indicator is based on the first measurement value and the second measurement value.
    Type: Application
    Filed: February 27, 2018
    Publication date: August 29, 2019
    Inventors: Xin WANG, Andrew E. YOUTZ, Hui ZHAO, Lily ZHU, Samirkumar PATEL, Balaji L. RAGHAVACHARI
  • Publication number: 20190240208
    Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
    Type: Application
    Filed: September 7, 2018
    Publication date: August 8, 2019
    Inventors: Vladimir ZARNITSYN, Samirkumar PATEL, Daniel WHITE, Glenn NORONHA, Brian BURKE
  • Publication number: 20190133933
    Abstract: The current disclosure relates to formulations and methods for reducing intraocular pressure (IOP) in the eye of a subject in need thereof. The disclosure also relates to formulations and methods for reducing intraocular pressure (IOP) related to glaucoma in a subject. The methods provided include non-surgically administering a non-pharmacologically active injectable formulation to the eye of the subject by using an apparatus that is suitable for delivering the formulations. The methods provided also include placing a solid implant into the eye of the subject to create a controlled space in the suprachoroidal space (SCS) or the supraciliary space of the eye of the subject in need thereof. The present disclosure further comprises facilitating and improving the aqueous outflows in the eye through the trabecular meshwork outflow pathway and/or uveoscleral outflow pathway and thereby decreasing the intraocular pressure.
    Type: Application
    Filed: May 1, 2017
    Publication date: May 9, 2019
    Inventors: Richard BECKMAN, Jesse YOO, Rafael Victor ANDINO, Glenn NORONHA, Samirkumar PATEL, Donna TARABORELLI, Vladimir ZARNITSYN
  • Patent number: 10275737
    Abstract: A user device may request an account type identifier that identifies an account type associated with the user device. The user device may receive the account type identifier based on requesting the account type identifier. The user device may compare the account type identifier and a set of account type identifiers corresponding to a set of user device configurations to be enabled or disabled by the user device based on the account type identifier. The user device may enable a first subset of user device configurations, included in the set of user device configurations that are associated with the account type identifier. The user device may disable a second subset of user device configurations, included in the set of user device configurations that are not associated with the account type identifier.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: April 30, 2019
    Assignee: Verizon Patent and Licensing Inc.
    Inventors: Zhengfang Chen, Masudur Rahman, Farook Kaleem, Samirkumar Patel
  • Publication number: 20180325884
    Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
    Type: Application
    Filed: July 20, 2018
    Publication date: November 15, 2018
    Inventors: Vladimir ZARNITSYN, Samirkumar PATEL, Daniel WHITE, Glenn NORONHA, Brian BURKE
  • Publication number: 20180092897
    Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
    Type: Application
    Filed: December 4, 2017
    Publication date: April 5, 2018
    Inventors: Vladimir Zarnitsyn, Samirkumar Patel, Daniel White, Glenn Noronha, Brian Burke
  • Patent number: 9931330
    Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: April 3, 2018
    Assignee: CLEARSIDE BIOMEDICAL, INC.
    Inventors: Vladimir Zarnitsyn, Samirkumar Patel, Daniel White, Glenn Noronha, Brian Burke